These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

360 related items for PubMed ID: 3057835

  • 41. Implications of persistent T cell abnormalities for the etiology of Hodgkin's disease.
    Fisher RI.
    Cancer Treat Rep; 1982 Apr; 66(4):681-7. PubMed ID: 6210434
    [Abstract] [Full Text] [Related]

  • 42. Immunomodulatory effects of interferons on human mononuclear cells with special reference to the expression of cell surface antigens.
    Hokland ME.
    Acta Pathol Microbiol Immunol Scand Suppl; 1985 Apr; 286():1-35. PubMed ID: 2408439
    [No Abstract] [Full Text] [Related]

  • 43. The potential role of innate immunity in the pathogenesis of Hodgkin's lymphoma.
    Enblad G, Molin D, Glimelius I, Fischer M, Nilsson G.
    Hematol Oncol Clin North Am; 2007 Oct; 21(5):805-23. PubMed ID: 17908621
    [Abstract] [Full Text] [Related]

  • 44. Distinguishing features of the immunology of Hodgkin's disease in children.
    Tan CT, De Sousa M, Good RA.
    Cancer Treat Rep; 1982 Apr; 66(4):969-75. PubMed ID: 7074657
    [Abstract] [Full Text] [Related]

  • 45. Advances in biology, diagnostics, and treatment of Hodgkin's disease.
    Küppers R, Yahalom J, Josting A.
    Biol Blood Marrow Transplant; 2006 Jan; 12(1 Suppl 1):66-76. PubMed ID: 16399588
    [Abstract] [Full Text] [Related]

  • 46. Hodgkin's disease--a histochemical study with special emphasis on the character of Hodgkin's cell and Reed-Sternberg cell.
    Umihara J, Tanaka M, Tanaka H, Saito K, Ishikawa E.
    Acta Pathol Jpn; 1983 Jul; 33(4):751-9. PubMed ID: 6137929
    [Abstract] [Full Text] [Related]

  • 47. Normal natural killer cell activity in Hodgkin's disease patients in remission.
    Douer D, Shaked N, Ramot B.
    Clin Exp Immunol; 1987 Sep; 69(3):660-7. PubMed ID: 3665188
    [Abstract] [Full Text] [Related]

  • 48. Some immunological parameters in Hodgkin's disease.
    Dienstbier Z, Hermanská Z, Pĕnicka P, Zámecník J.
    Neoplasma; 1988 Sep; 35(1):51-60. PubMed ID: 3352837
    [Abstract] [Full Text] [Related]

  • 49. Hodgkin's disease: pathology and pathogenesis.
    Howard DR.
    Crit Rev Clin Lab Sci; 1981 Sep; 14(2):109-31. PubMed ID: 7016439
    [Abstract] [Full Text] [Related]

  • 50. Suppressor cells of the mixed lymphocyte reaction in patients with Hodgkin's disease.
    Engleman EG, Benike C, Hoppe RT, Kaplan HS.
    Transplant Proc; 1979 Dec; 11(4):1827-9. PubMed ID: 161096
    [No Abstract] [Full Text] [Related]

  • 51. Comparative studies of the proportions of T, B and zero lymphocytes and the degrees of blastic transformation of lymphocytes after stimulation by PHA and CON A in patients with Hodgkin's disease.
    Pluzańska A.
    Haematol Blood Transfus; 1977 Dec; 20():203-7. PubMed ID: 305396
    [No Abstract] [Full Text] [Related]

  • 52. Leu-M1--a marker for Reed-Sternberg cells in Hodgkin's disease. An immunoperoxidase study of paraffin-embedded tissues.
    Pinkus GS, Thomas P, Said JW.
    Am J Pathol; 1985 May; 119(2):244-52. PubMed ID: 3887932
    [Abstract] [Full Text] [Related]

  • 53. Occurrence of monocytoid B-lymphocytes in Hodgkin's disease.
    Ohsawa M, Kanno H, Naka N, Aozasa K.
    Mod Pathol; 1994 Jun; 7(5):540-3. PubMed ID: 7937719
    [Abstract] [Full Text] [Related]

  • 54. [Morphological classification and problems of lymphogranulomatosis (Hodgkin's disease) (author's transl)].
    Wöckel W.
    Arch Geschwulstforsch; 1980 Jun; 50(1):25-35. PubMed ID: 7004386
    [Abstract] [Full Text] [Related]

  • 55. [Interferon influences the immunologic defense of the body--an important physiological immunity-regulating function?].
    Kiessling R, Gidlund M.
    Lakartidningen; 1985 Jul 24; 82(30-31):2593-7. PubMed ID: 2410747
    [No Abstract] [Full Text] [Related]

  • 56. Cytotoxic protein expression in non-Hodgkin's lymphomas and Hodgkin's disease.
    Kanavaros P, Vlychou M, Stefanaki K, Rontogianni D, Gaulard P, Pantelidaki E, Zois M, Darivianaki K, Georgoulias V, Boulland ML, Gorgoulis V, Kittas C.
    Anticancer Res; 1999 Jul 24; 19(2A):1209-16. PubMed ID: 10368677
    [Abstract] [Full Text] [Related]

  • 57. Neoplastic cells obtained from Hodgkin's disease function as accessory cells for mitogen-induced human T cell proliferative responses.
    Fisher RI, Bates SE, Bostick-Bruton F, Tuteja N, Diehl V.
    J Immunol; 1984 May 24; 132(5):2672-7. PubMed ID: 6609204
    [Abstract] [Full Text] [Related]

  • 58. Vascular endothelial growth factor (VEGF) is expressed by neoplastic Hodgkin-Reed-Sternberg cells in Hodgkin's disease.
    Doussis-Anagnostopoulou IA, Talks KL, Turley H, Debnam P, Tan DC, Mariatos G, Gorgoulis V, Kittas C, Gatter KC.
    J Pathol; 2002 Aug 24; 197(5):677-83. PubMed ID: 12210089
    [Abstract] [Full Text] [Related]

  • 59. Epidermotropic lymphomas. Introductory immunological remarks.
    Wybran J.
    Dermatologica; 1978 Aug 24; 157(6):341-4. PubMed ID: 309836
    [Abstract] [Full Text] [Related]

  • 60. On the natural biology of the malignant cells in Hodgkin's disease.
    Olsson L.
    Int J Radiat Oncol Biol Phys; 1985 Jan 24; 11(1):37-48. PubMed ID: 3871433
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.